MedPath

Inovobiologic Inc.

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

Phase 3
Terminated
Conditions
Type II Diabetes Mellitus
Obesity
First Posted Date
2012-07-19
Last Posted Date
2021-02-11
Lead Sponsor
InovoBiologic Inc.
Target Recruit Count
100
Registration Number
NCT01644201
Locations
🇨🇦

Wharton Medical Clinic and Weight Management Centre, Hamilton, Ontario, Canada

News

No news found
© Copyright 2025. All Rights Reserved by MedPath